Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.

Kesselheim AS, Tan YT, Avorn J.

Health Aff (Millwood). 2015 Feb;34(2):286-93. doi: 10.1377/hlthaff.2014.1038.

PMID:
25646109
2.

Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs.

Kesselheim AS, Tan YT, Darrow JJ, Avorn J.

Health Aff (Millwood). 2014 Oct;33(10):1770-8. doi: 10.1377/hlthaff.2014.0529.

PMID:
25288421
3.

Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.

Kramer DB, Tan YT, Sato C, Kesselheim AS.

Food Drug Law J. 2014;69(1):1-23, i.

4.

Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China.

Kramer DB, Tan YT, Sato C, Kesselheim AS.

PLoS Med. 2013;10(9):e1001519. doi: 10.1371/journal.pmed.1001519. Epub 2013 Sep 24. No abstract available.

Supplemental Content

Loading ...
Support Center